Fundraising Fox

Commodore Capital

Venture capital

New York · Series C–Late Stage · 12 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

Commodore Capital believes the biopharmaceutical industry is in the early stages of a major innovation cycle, driven by scientific discoveries translating into clinical breakthroughs through novel therapeutic modalities such as genetic medicines and cellular therapies. The firm notes that innovation has shifted from large pharmaceutical companies to smaller biopharmaceutical firms. Commodore aims to be a supportive partner to these companies as they work to bring safe and effective new medicines to patients worldwide.

Source: firm website, verified Aug 18, 2026.

Stage
Series C–Late Stage
HQ
New York, New York, US
Leads rounds
Follows
Instruments
Equity
Founded
2019
Last 12 months
1 investment
AUM
$2.4B
Tracked investments
1

Team · 12 people

from the firm's website & public directories

What they invest in

from 1 of 1 portfolio companies

Biotech ×1Healthtech ×1Medical Devices ×1

HQs:United States×1

Investments · 1 tracked

founders shown can be your intro path
Agenusagenusbio.comNASDAQ: AGENAug 2026

BiotechHealthtechMedical DevicesLexington, US

Garo Armen(Executive Officer, Director)Ozer Baysal(Executive Officer)Robert Stein(Executive Officer)Christine Klaskin(Executive Officer)Karen Valentine(Executive Officer)

BoardBrian Corvese(Director)

Co-investorsAdvent Life SciencesGrazia Equity GmbHHEALTHCARE ROYALTY PARTNERSOberland CapitalInvusLigand Pharmaceuticals+1 more

Exits · 1

IPOs and acquisitions across the tracked portfolio

AgenusNASDAQ: AGEN

Portfolio news

latest coverage across their companies

Frequently asked questions

What stage does Commodore Capital invest at?
Commodore Capital invests at the Series C, Late Stage stages.
What sectors does Commodore Capital focus on?
Commodore Capital focuses on Biotech.
Where is Commodore Capital located?
Commodore Capital is headquartered in New York, US.
Does Commodore Capital lead rounds?
Commodore Capital typically participates in rounds rather than leading them.

Similar investors

Featured in lists